INKT - MiNK Therapeutics GAAP EPS of -$0.23 May, 10 2022 08:09 AM MiNK Therapeutics Inc. MiNK Therapeutics press release (NASDAQ:INKT): Q1 GAAP EPS of -$0.23. Cash balance of $34.7 million as compared to $38.9 million at December 31, 2021. For further details see: MiNK Therapeutics GAAP EPS of -$0.23